Azam Muhammad Abid, Latman Vered Valeria, Katz Joel
York University, Toronto, ON, Canada.
JMIR Res Protoc. 2019 Dec 2;8(12):e14119. doi: 10.2196/14119.
Mindfulness meditation (MM) is a commonly used psychological intervention for pain, mood, and anxiety conditions, but can be challenging to practice with severe symptoms without proper training. The Mindfulness Meditation app (MMA) is a supportive training tool specifically developed for this study to aid in the practice of mindful breathing using a smartphone.
This study aims to evaluate the psychophysiological effects of the MMA. Specifically, the study will assess parasympathetic functioning using heart rate variability (HRV; primary outcome), pain and mood symptoms, mind-wandering and present moment awareness, and breath focus in groups of undergraduate participants who self-report clinically-relevant symptoms of chronic pain (CP) and depression or anxiety (DA) and condition-free (CF) participants who do not meet either criteria. We hypothesize that use of the MMA by study groups will lead to improved HRV, pain, and mood symptoms compared with groups who do not use the app.
This study is a two-arm randomized controlled trial (RCT) recruiting through a Web-based research participation pool at York University in Toronto, Canada. We are aiming for minimum 60 participants in each of CP, DA, and CF groups. Upon arriving to the laboratory, participants will be prescreened for classification into groups of CP, DA, or CF. Groups will be randomly assigned by a 1:1 ratio to an MMA (MMA+) condition or MM condition without the app (MMA-) after a brief stress induction procedure. In MMA+, participants will practice mindful breathing with a smartphone and press breath or other buttons at the sound of audio tones if their awareness was on breathing or another experience, respectively. HRV and respiration data will be obtained during rest (5 min), stress induction (5 min), and meditation conditions (12 min). Participants will complete psychological self-report inventories before and after the stress induction and after the meditation condition. Separate linear mixed models will be used to examine HRV and self-report inventories comparing groups and treatment conditions.
Recruitment for the study began in November 2017 and is expected to be completed in winter of 2019-2020. As of July 2019, 189 participants have been recruited. The study's main findings are expected to reveal a positive pattern of HRV responses in the CP, DA, and CF groups, such that a significant increase in HRV (P<.05) is detected in those randomized to the MMA+ condition in comparison with those randomized to the MMA- condition.
This RCT will contribute to the burgeoning health psychology literature regarding the clinical relevance of HRV in assessment and treatment of psychological and medical conditions. Furthermore, possible ways to inform designs of MM training tools delivered by apps and Web platforms for CP, depression, and anxiety conditions' treatment will be discussed.
Clinicaltrials.gov NCT03296007; https://clinicaltrials.gov/ct2/show/NCT03296007.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/14119.
正念冥想(MM)是一种常用于缓解疼痛、改善情绪和焦虑状况的心理干预方法,但对于症状严重且未经适当训练的人来说,进行正念冥想可能具有挑战性。正念冥想应用程序(MMA)是专门为这项研究开发的一种辅助训练工具,用于借助智能手机辅助进行正念呼吸练习。
本研究旨在评估MMA的心理生理效应。具体而言,该研究将通过心率变异性(HRV;主要指标)评估副交感神经功能,以及评估慢性疼痛(CP)、抑郁或焦虑(DA)的自我报告临床相关症状的本科参与者组和不符合上述任何标准的无相关症状(CF)参与者组中的疼痛和情绪症状、思绪游离和当下觉察,以及呼吸专注度。我们假设,与未使用该应用程序的组相比,研究组使用MMA将改善HRV、疼痛和情绪症状。
本研究是一项双臂随机对照试验(RCT),通过加拿大多伦多约克大学基于网络的研究参与库招募参与者。我们的目标是CP组、DA组和CF组每组至少招募60名参与者。参与者到达实验室后,将进行预筛查以分类到CP组、DA组或CF组。在经过简短的应激诱导程序后,各小组将按1:1的比例随机分配到MMA(MMA+)组或不使用该应用程序的MM组(MMA-)。在MMA+组中,参与者将使用智能手机进行正念呼吸练习,如果他们的注意力集中在呼吸或其他体验上,分别在听到音频提示音时按下呼吸或其他按钮。将在静息状态(5分钟)、应激诱导状态(5分钟)和冥想状态(12分钟)期间获取HRV和呼吸数据。参与者将在应激诱导前后以及冥想状态后完成心理自我报告量表。将使用单独的线性混合模型来检查HRV和自我报告量表,比较各小组和治疗条件。
该研究于2017年11月开始招募,预计于2019 - 2020年冬季完成。截至2019年7月,已招募189名参与者。该研究的主要结果预计将揭示CP组、DA组和CF组中HRV反应的积极模式,即与随机分配到MMA-组的参与者相比,随机分配到MMA+组的参与者中检测到HRV显著增加(P <.05)。
这项RCT将为新兴的健康心理学文献做出贡献,这些文献涉及HRV在心理和医学状况评估与治疗中的临床相关性。此外,还将讨论为CP、抑郁和焦虑状况的治疗而设计的由应用程序和网络平台提供的MM训练工具的可能方法。
Clinicaltrials.gov NCT03296007;https://clinicaltrials.gov/ct2/show/NCT03296007。
国际注册报告识别码(IRRID):DERR1-10.2196/14119。